Clinical Trial Update: Prevention of Chemotherapy Induced Cardiotoxicity in Children With Bone Tumors and Acute Myeloid Leukemia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating prevention of chemotherapy-induced cardiotoxicity in children with bone tumors and acute myeloid leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia in Children
• Bone Tumor
• Cardiotoxicity

Snippet

Sponsor: Children's Cancer Hospital Egypt 57357 | Conditions: Cardiotoxicity, Acute Myeloid Leukemia in Children | Phase 3 | Status: COMPLETED